IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced details of its poster presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback